カテゴリ： GlobalData, ドイツ, 企業調査

Curetis NV (CURE)：企業の製品パイプライン分析2018

◆英語タイトル：Curetis NV (CURE) - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C2786
◆発行会社（調査会社）：GlobalData
◆発行日：2018年8月
◆ページ数：62
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company provides diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for cartridges, diseases such as implant and tissue infections, and pneumonia; and also used in the laboratory for multiplex polymerase chain reaction pcr diagnostics. Curetis serves medical, healthcare companies, biotechnology, contract research and pharmaceutical companies, among others. The company sells its products through a network of distributors located across Germany. It has its operations in in France, Switzerland, Netherlands, the UK, the US and Germany. Curetis is headquartered in Stuttgart, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Curetis NV
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Curetis NV Company Overview 6
Curetis NV Company Snapshot 6
Curetis NV Pipeline Products and Ongoing Clinical Trials Overview 6
Curetis NV – Pipeline Analysis Overview 9
Curetis NV – Key Facts 9
Curetis NV – Major Products and Services 10
Curetis NV Pipeline Products by Development Stage 11
Curetis NV Ongoing Clinical Trials by Trial Status 15
Curetis NV Pipeline Products Overview 17
Gyronimo Analyzer 17
Gyronimo Analyzer Product Overview 17
Next Generation Unyvero Implant & Tissue Infections Cartridge 18
Next Generation Unyvero Implant & Tissue Infections Cartridge Product Overview 18
Next-Generation Sequencing Assay – Microbial Infections 19
Next-Generation Sequencing Assay – Microbial Infections Product Overview 19
Unyvero A30 RQ Application Cartridge 20
Unyvero A30 RQ Application Cartridge Product Overview 20
Unyvero Analyzer 21
Unyvero Analyzer Product Overview 21
UNYVERO ANALYZER A30 – CNS Infection 22
UNYVERO ANALYZER A30 – CNS Infection Product Overview 22
UNYVERO ANALYZER A30 – ICO 23
UNYVERO ANALYZER A30 – ICO Product Overview 23
UNYVERO ANALYZER A30 – RVP 24
UNYVERO ANALYZER A30 – RVP Product Overview 24
Unyvero Analyzer A30 RQ 25
Unyvero Analyzer A30 RQ Product Overview 25
Unyvero Analyzer A30 RQ – Immuno-Compromised Patient Panel 26
Unyvero Analyzer A30 RQ – Immuno-Compromised Patient Panel Product Overview 26
Unyvero BCU Cartridge 27
Unyvero BCU Cartridge Product Overview 27
Unyvero BCU Cartridge Clinical Trial 28
Unyvero Cardiology Infection Cartridge 29
Unyvero Cardiology Infection Cartridge Product Overview 29
Unyvero CNS Infections Cartridge 30
Unyvero CNS Infections Cartridge Product Overview 30
Unyvero Extended Respiratory Infection Cartridge 31
Unyvero Extended Respiratory Infection Cartridge Product Overview 31
Unyvero HPN Catridge 32
Unyvero HPN Catridge Product Overview 32
Unyvero i60 Cartridge 33
Unyvero i60 Cartridge Product Overview 33
Unyvero IAI Cartridge 34
Unyvero IAI Cartridge Product Overview 34
Unyvero IJI Cartridge 35
Unyvero IJI Cartridge Product Overview 35
Unyvero IJI Cartridge Clinical Trial 36
Unyvero LRT55 Cartridge – Bronchial Lavage Samples 37
Unyvero LRT55 Cartridge – Bronchial Lavage Samples Product Overview 37
Unyvero LRT55 Cartridge – Tracheal Aspirate Samples 38
Unyvero LRT55 Cartridge – Tracheal Aspirate Samples Product Overview 38
Unyvero LRT55 Cartridge – Tracheal Aspirate Samples Clinical Trial 39
Unyvero LRT55 Lower Respiratory Tract Cartridge 40
Unyvero LRT55 Lower Respiratory Tract Cartridge Product Overview 40
Unyvero P50 LRT Cartridge 41
Unyvero P50 LRT Cartridge Product Overview 41
Unyvero Pediatric Infections Cartridge 42
Unyvero Pediatric Infections Cartridge Product Overview 42
Unyvero Sepsis Host Response Cartridge 43
Unyvero Sepsis Host Response Cartridge Product Overview 43
Unyvero Sepsis Host Response Cartridge Clinical Trial 44
Unyvero Tuberculosis Cartridge 45
Unyvero Tuberculosis Cartridge Product Overview 45
Curetis NV – Key Competitors 46
Curetis NV – Key Employees 47
Curetis NV – Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Recent Developments 49
Curetis NV, Recent Developments 49
Jun 07, 2018: Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S. 49
May 18, 2018: Curetis Publishes Business and Financial Update for the First Quarter 2018 49
Apr 30, 2018: Curetis Publishes Full-Year 2017 Financial Results and Updated Guidance For 2018 51
Apr 19, 2018: Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection Cartridge at ECCMID 2018 53
Apr 18, 2018: Curetis: Novel Products and Study Data to be Presented at ECCMID 2018 54
Apr 11, 2018: Curetis Establishes U.S. Scientific Advisory Board 54
Apr 04, 2018: Curetis” Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority 56
Apr 03, 2018: Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge 57
Mar 14, 2018: Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology 58
Mar 06, 2018: Curetis subsidiary Ares Genetics wins incubator stay in Silicon Valley 58
Appendix 59
Methodology 59
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
Curetis NV Pipeline Products and Ongoing Clinical Trials Overview 6
Curetis NV Pipeline Products by Equipment Type 7
Curetis NV Pipeline Products by Indication 8
Curetis NV Ongoing Clinical Trials by Trial Status 8
Curetis NV, Key Facts 9
Curetis NV, Major Products and Services 10
Curetis NV Number of Pipeline Products by Development Stage 11
Curetis NV Pipeline Products Summary by Development Stage 12
Curetis NV Ongoing Clinical Trials by Trial Status 15
Curetis NV Ongoing Clinical Trials Summary 16
Gyronimo Analyzer - Product Status 17
Gyronimo Analyzer - Product Description 17
Next Generation Unyvero Implant & Tissue Infections Cartridge - Product Status 18
Next Generation Unyvero Implant & Tissue Infections Cartridge - Product Description 18
Next-Generation Sequencing Assay - Microbial Infections - Product Status 19
Next-Generation Sequencing Assay - Microbial Infections - Product Description 19
Unyvero A30 RQ Application Cartridge - Product Status 20
Unyvero A30 RQ Application Cartridge - Product Description 20
Unyvero Analyzer - Product Status 21
Unyvero Analyzer - Product Description 21
UNYVERO ANALYZER A30 - CNS Infection - Product Status 22
UNYVERO ANALYZER A30 - CNS Infection - Product Description 22
UNYVERO ANALYZER A30 - ICO - Product Status 23
UNYVERO ANALYZER A30 - ICO - Product Description 23
UNYVERO ANALYZER A30 - RVP - Product Status 24
UNYVERO ANALYZER A30 - RVP - Product Description 24
Unyvero Analyzer A30 RQ - Product Status 25
Unyvero Analyzer A30 RQ - Product Description 25
Unyvero Analyzer A30 RQ - Immuno-Compromised Patient Panel - Product Status 26
Unyvero Analyzer A30 RQ - Immuno-Compromised Patient Panel - Product Description 26
Unyvero BCU Cartridge - Product Status 27
Unyvero BCU Cartridge - Product Description 27
Unyvero BCU Cartridge - External, Prospective, Multicenter Evaluation Comparing the Performance of the BCU Application Cartridge against the Performance of Conventional Microbiology Work-Up 28
Unyvero Cardiology Infection Cartridge - Product Status 29
Unyvero Cardiology Infection Cartridge - Product Description 29
Unyvero CNS Infections Cartridge - Product Status 30
Unyvero CNS Infections Cartridge - Product Description 30
Unyvero Extended Respiratory Infection Cartridge - Product Status 31
Unyvero Extended Respiratory Infection Cartridge - Product Description 31
Unyvero HPN Catridge - Product Status 32
Unyvero HPN Catridge - Product Description 32
Unyvero i60 Cartridge - Product Status 33
Unyvero i60 Cartridge - Product Description 33
Unyvero IAI Cartridge - Product Status 34
Unyvero IAI Cartridge - Product Description 34
Unyvero IJI Cartridge - Product Status 35
Unyvero IJI Cartridge - Product Description 35
Unyvero IJI Cartridge - Clinical Study of Unyvero IJI Cartridge for the Detection of Invasive Joint Infections 36
Unyvero LRT55 Cartridge - Bronchial Lavage Samples - Product Status 37
Unyvero LRT55 Cartridge - Bronchial Lavage Samples - Product Description 37
Unyvero LRT55 Cartridge - Tracheal Aspirate Samples - Product Status 38
Unyvero LRT55 Cartridge - Tracheal Aspirate Samples - Product Description 38
Unyvero LRT55 Cartridge - Tracheal Aspirate Samples - Clinical CE Performance Evaluation of Unyvero P55 Pneumonia Application 39
Unyvero LRT55 Lower Respiratory Tract Cartridge - Product Status 40
Unyvero LRT55 Lower Respiratory Tract Cartridge - Product Description 40
Unyvero P50 LRT Cartridge - Product Status 41
Unyvero P50 LRT Cartridge - Product Description 41
Unyvero Pediatric Infections Cartridge - Product Status 42
Unyvero Pediatric Infections Cartridge - Product Description 42
Unyvero Sepsis Host Response Cartridge - Product Status 43
Unyvero Sepsis Host Response Cartridge - Product Description 43
Unyvero Sepsis Host Response Cartridge - Bedside Versus Standard Microbiological Blood Culture Diagnostics: BEMIDIA Study 44
Unyvero Tuberculosis Cartridge - Product Status 45
Unyvero Tuberculosis Cartridge - Product Description 45
Curetis NV, Key Employees 47
Curetis NV, Other Locations 48
Curetis NV, Subsidiaries 48
Glossary 61

List of Figures
Curetis NV Pipeline Products by Equipment Type 7
Curetis NV Pipeline Products by Development Stage 11
Curetis NV Ongoing Clinical Trials by Trial Status 15

★海外企業調査レポート[Curetis NV (CURE)：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • China Tontine Wines Group Limited：企業の戦略・SWOT・財務情報
    China Tontine Wines Group Limited - Strategy, SWOT and Corporate Finance Report Summary China Tontine Wines Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Vodacom Group Limited：企業の戦略・SWOT・財務情報
    Vodacom Group Limited - Strategy, SWOT and Corporate Finance Report Summary Vodacom Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Phibro Animal Health Corp (PAHC)：企業の財務・戦略的SWOT分析
    Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Compagnie Financiere Richemont SA：企業の戦略・SWOT・財務情報
    Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report Summary Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • PolyNovo Ltd (PNV)-医療機器分野：企業M&A・提携分析
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd is a medical device company that develops, manufactures and commercializes biodegradable polymers for use in medical devices. The company offers products such as biodegradable temporizing matrix and negative pressure wound therapy dressing system …
  • Hebron Technology Co., Ltd. (HEBT)：企業の財務・戦略的SWOT分析
    Hebron Technology Co., Ltd. (HEBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Vanda Pharmaceuticals Inc (VNDA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Vanda Pharmaceuticals Inc (Vanda Pharmaceuticals) is a specialty pharmaceutical company that develops and commercializesnovel therapies for the treatment of central nervous system disorders. The company’s products include Hetlioz, a melatonin receptor agonist for the treatment of non-24-hour …
  • Lycatel Services Ltd：企業の戦略的SWOT分析
    Lycatel Services Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • The Talbots, Inc.：企業の戦略的SWOT分析
    The Talbots, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • National Shipping Company of Saudi Arabia (4030)：企業の財務・戦略的SWOT分析
    National Shipping Company of Saudi Arabia (4030) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • International AIDS Vaccine Initiative-製薬・医療分野：企業M&A・提携分析
    Summary International AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, discovery, preclinical evaluation and manufacturing, and regulatory review, among others. It also …
  • Grupo Nutresa SA (NUTRESA)：企業の財務・戦略的SWOT分析
    Grupo Nutresa SA (NUTRESA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Nurix Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Nurix Inc (Nurix) formerly Kura Therapeutics Inc, is a drug development company that discovers and develops drugs which work by modulating the protein regulation machinery of the cell. The company developed a drug discovery platform based on understanding of the ubiquitin proteasome system ( …
  • The Hokkaido Bank Ltd：企業の戦略・SWOT・財務情報
    The Hokkaido Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Hokkaido Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Weight Watchers International, Inc. (WW)：企業の財務・戦略的SWOT分析
    Weight Watchers International, Inc. (WW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Tiziana Life Sciences Plc (TILS)：医療機器：M&Aディール及び事業提携情報
    Summary Tiziana Life Sciences Plc (Tiziana), formerly Alexander David Investments Plc, is a clinical stage biotechnology company that discovers and develops drugs to treat diseases in oncology and immunology. The company’s lead product candidate, TZLS-201, intended for the treatment of thymic carcin …
  • Lukoil Oil Co (LKOH)：企業の財務・戦略的SWOT分析
    Lukoil Oil Co (LKOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Amsted Industries Inc：企業の戦略・SWOT・財務情報
    Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Federal Reserve System：企業の戦略的SWOT分析
    The Federal Reserve System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Vodacom Group Ltd (VOD)：企業の財務・戦略的SWOT分析
    Vodacom Group Ltd (VOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆